223 related articles for article (PubMed ID: 15683114)
1. Use of complementary and alternative medicine among Korean cancer patients.
Kim MJ; Lee SD; Kim DR; Kong YH; Sohn WS; Ki SS; Kim J; Kim YC; Han CJ; Lee JO; Nam HS; Park YH; Kim CH; Yi KH; Lee YY; Jeong SH
Korean J Intern Med; 2004 Dec; 19(4):250-6. PubMed ID: 15683114
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, patterns, and perceived value of complementary and alternative medicine among cancer patients: a cross-sectional, descriptive study.
Bahall M
BMC Complement Altern Med; 2017 Jun; 17(1):345. PubMed ID: 28666435
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with discontinuation of complementary and alternative medicine among Korean cancer patients.
Kim SY; Kim KS; Park JH; Shin JY; Kim SK; Park JH; Park EC; Seo HG
Asian Pac J Cancer Prev; 2013; 14(1):225-30. PubMed ID: 23534728
[TBL] [Abstract][Full Text] [Related]
4. Complementary and alternative medicine use by patients with cancer in Wales: a cross sectional survey.
Harris P; Finlay IG; Cook A; Thomas KJ; Hood K
Complement Ther Med; 2003 Dec; 11(4):249-53. PubMed ID: 15022659
[TBL] [Abstract][Full Text] [Related]
5. Use of complementary and alternative medicine in cancer: A Tunisian single-center experience.
Labidi S; Ennouri S; Rachdi H; El Benna H; Mejri N; Daoud N; Berrazaga Y; Boussen H
Bull Cancer; 2020 Feb; 107(2):209-214. PubMed ID: 32000968
[TBL] [Abstract][Full Text] [Related]
6. An assessment of the use of complementary and alternative medicine by Korean people using an adapted version of the standardized international questionnaire (I-CAM-QK): a cross-sectional study of an internet survey.
Lee JA; Sasaki Y; Arai I; Go HY; Park S; Yukawa K; Nam YK; Ko SG; Motoo Y; Tsutani K; Lee MS
BMC Complement Altern Med; 2018 Aug; 18(1):238. PubMed ID: 30103722
[TBL] [Abstract][Full Text] [Related]
7. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre.
Chrystal K; Allan S; Forgeson G; Isaacs R
N Z Med J; 2003 Jan; 116(1168):U296. PubMed ID: 12601420
[TBL] [Abstract][Full Text] [Related]
8. Complementary and Alternative Medicine Use and Its Association with Emotional Status and Quality of Life in Patients with a Solid Tumor: A Cross-Sectional Study.
Jang A; Kang DH; Kim DU
J Altern Complement Med; 2017 May; 23(5):362-369. PubMed ID: 28453297
[TBL] [Abstract][Full Text] [Related]
9. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.
Richardson MA; Sanders T; Palmer JL; Greisinger A; Singletary SE
J Clin Oncol; 2000 Jul; 18(13):2505-14. PubMed ID: 10893280
[TBL] [Abstract][Full Text] [Related]
10. A cross-sectional survey of complementary and alternative medicine use by children and adolescents attending the University Hospital of Wales.
Crawford NW; Cincotta DR; Lim A; Powell CV
BMC Complement Altern Med; 2006 May; 6():16. PubMed ID: 16670012
[TBL] [Abstract][Full Text] [Related]
11. Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study.
Kang E; Yang EJ; Kim SM; Chung IY; Han SA; Ku DH; Nam SJ; Yang JH; Kim SW
Support Care Cancer; 2012 Mar; 20(3):461-73. PubMed ID: 21274576
[TBL] [Abstract][Full Text] [Related]
12. Complementary and alternative medicine among Singapore cancer patients.
Chow WH; Chang P; Lee SC; Wong A; Shen HM; Verkooijen HM
Ann Acad Med Singap; 2010 Feb; 39(2):129-35. PubMed ID: 20237735
[TBL] [Abstract][Full Text] [Related]
13. Complementary and alternative medicine (CAM) in Mexican patients with cancer.
Gerson-Cwilich R; Serrano-Olvera A; Villalobos-Prieto A
Clin Transl Oncol; 2006 Mar; 8(3):200-7. PubMed ID: 16648120
[TBL] [Abstract][Full Text] [Related]
14. Complementary and alternative medicine use among cancer patients at the end of life: Korean national study.
Choi JY; Chang YJ; Hong YS; Heo DS; Kim S; Lee JL; Choi JS; Kang KM; Kim SY; Jeong HS; Lee CG; Choi YS; Lim HY; Yun YH
Asian Pac J Cancer Prev; 2012; 13(4):1419-24. PubMed ID: 22799342
[TBL] [Abstract][Full Text] [Related]
15. The use of complementary and alternative medicine by patients in routine care and the risk of interactions.
Firkins R; Eisfeld H; Keinki C; Buentzel J; Hochhaus A; Schmidt T; Huebner J
J Cancer Res Clin Oncol; 2018 Mar; 144(3):551-557. PubMed ID: 29356888
[TBL] [Abstract][Full Text] [Related]
16. Use of complementary and alternative medicine by lymphoma survivors in South Korea.
Kim K; Kim SH; Ok ON; Kim IR; Lee S; Kim SH; Kim WS; Ryu MH; Lee MH
Eur J Oncol Nurs; 2018 Apr; 33():91-96. PubMed ID: 29551184
[TBL] [Abstract][Full Text] [Related]
17. Study of the use of complementary and alternative medicine by cancer patients at Kenyatta National Hospital, Nairobi, Kenya.
Ong'udi M; Mutai P; Weru I
J Oncol Pharm Pract; 2019 Jun; 25(4):918-928. PubMed ID: 30319064
[TBL] [Abstract][Full Text] [Related]
18. Complementary and alternative medicine use by gynecologic oncology patients in Turkey.
Nazik E; Nazik H; Api M; Kale A; Aksu M
Asian Pac J Cancer Prev; 2012; 13(1):21-5. PubMed ID: 22502670
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and correlates of complementary and alternative medicine use among cancer patients in usmanu danfodiyo university teaching hospital, Sokoto, Nigeria.
Aliyu UM; Awosan KJ; Oche MO; Taiwo AO; Jimoh AO; Okuofo EC
Niger J Clin Pract; 2017 Dec; 20(12):1576-1583. PubMed ID: 29378990
[TBL] [Abstract][Full Text] [Related]
20. Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria.
Ezeome ER; Anarado AN
BMC Complement Altern Med; 2007 Sep; 7():28. PubMed ID: 17850665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
